FDA: seeks input on Study Data Exchange Standards. With attachment

Dear colleagues,

A reaction by the EN13606 Association in response to:
>  a request by the FDA on questions such as "- What are the advantages and disadvantages of HL7 v3 and CDISC ODM?"
> And, interestingly, they also ask: "- Are there other open data exchange standards that should be evaluated?"


See the attachment.


With regards,

Gerard Freriks

EN13606 Association
p/a Huigsloterdijk 378
2158 LR Buitenkaag
The Netherlands

M: 	+31 620347088
E:     gerard.freriks@EN13606.org
W:	http:www.en13606.org